Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 5Genitourinary 4Other 2Gastrointestinal 2Breast 2Sarcoma 1Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 64Breast Neoplasms 15Urinary Bladder Neoplasms 12Colorectal Neoplasms 9Carcinoma, Renal Cell 8Kidney Neoplasms 7Lung Neoplasms 6Neoplasm Metastasis 4Gastrointestinal Neoplasms 4Testicular Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Urogenital Neoplasms 2Urinary Incontinence 2Head and Neck Neoplasms 2Erectile Dysfunction 2Disease 2Depression 2Carcinoma, Transitional Cell 2Anxiety Disorders 2Adenocarcinoma 2Wilms Tumor 1Vomiting 1Varicocele 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Abnormalities 1Urinary Bladder, Overactive 1Thyroid Neoplasms 1

Interventions

Docetaxel 35pembrolizumab 32Nivolumab 27enzalutamide 20Prednisone 20Sunitinib 16Cyclophosphamide 16aldesleukin 14Zoledronic Acid 13Interleukin-2 13Gemcitabine 13Bevacizumab 13Specimen Handling 12Ipilimumab 12Radiosurgery 11Everolimus 11Androgen Antagonists 11Abiraterone Acetate 11fludarabine 10Sorafenib 10Radiotherapy 10Paclitaxel 10Magnetic Resonance Spectroscopy 10pazopanib 9abiraterone 9Doxorubicin 8Carboplatin 8Biopsy 8avelumab 7temsirolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Surveys and Questionnaires × Genitourinary × Clear all
NCT06046131 2025-11-17

KP-CARAIBES

Centre Hospitalier Universitaire de la Guadeloupe

Phase NA Recruiting
3,000 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Terminated
799 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01751438 2023-04-27

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

M.D. Anderson Cancer Center

Phase 2 Completed
180 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01392183 2021-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

M.D. Anderson Cancer Center

Phase 2 Completed
69 enrolled 15 charts
Genitourinary

Pathologic Complete Response, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡